Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 08/14/20
Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 07/28/20
Avenue Therapeutics, Inc. (ATXI) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 07/22/20
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study ResultsGlobeNewsWire • 07/21/20
Is Avenue Therapeutics (ATXI) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 07/09/20
Avenue Therapeutics, Inc. (ATXI) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 06/24/20
Is Avenue Therapeutics (ATXI) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 06/17/20
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 05/11/20
Avenue Therapeutics, Inc. (ATXI) Upgraded to Strong Buy: Here's WhyZacks Investment Research • 04/16/20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDAGlobeNewsWire • 02/13/20
Avenue Therapeutics Announces Submission of New Drug Application for IV TramadolGlobeNewsWire • 12/11/19